FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, and aims at treating patient's oral diseases. Cultured tissue constructs of fibroblast dermal cells are implanted onto the oral tissue. The cultured tissue constructs comprise the cultured cells and endogenous-produced extracellular matrix components without the exogenous matrix or network sustaining or scaffold links.
EFFECT: group of inventions enables providing more simple and less painful treatment of the oral diseases requiring the implanted tissue constructs to be used.
33 cl, 36 ex, 21 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| OCCLUDER FOR TRANSCUTANEOUS TRANSLUMINAL PROCEDURE (VERSIONS), METHOD OF TRANSCUTANEOUS TRANSLUMINAL CLOSING OF HOLE IN HEART, METHOD OF ACTIVISATION OF MAMMALIAN TISSUE VASCULARISATION IN VIVO AND METHOD OF ACTIVISATION OF ANASTOMOSIS PLACE HEALING | 2007 |
|
RU2470611C2 |
| BIOENGINEERED CONSTRUCT FOR TISSUE IMPLANTATION AND METHOD FOR MAKING SAID BIOENGINEERED CONSTRUCT (VERSIONS) | 2008 |
|
RU2461622C2 |
| TISSUE STRUCTURES OBTAINED BY BIOENGINEERING, AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2011 |
|
RU2645473C2 |
| BIOACTIVE COMPLEX FOR ORGANOGENESIS | 2003 |
|
RU2254146C2 |
| COMPOSITION EQUIVALENT OF LIVING SKIN, METHOD OF ITS PREPARING, TEST-SET | 1991 |
|
RU2135191C1 |
| ENGINEERED LEATHER EQUIVALENT, METHOD FOR PRODUCTION THEREOF AND PRODUCTS OBTAINED THEREFROM | 2017 |
|
RU2820590C2 |
| SKIN EQUIVALENT AND METHOD FOR ITS PRODUCTION | 2006 |
|
RU2342164C2 |
| STERILE AUTOLOGOUS, ALLOGENIC OR XENOGENIC IMPLANTS AND METHOD FOR MAKING IT | 2008 |
|
RU2478403C2 |
| COMPOSITIONS SUITABLE TO TREAT DERMAL SIGNS OF AGING | 2005 |
|
RU2409290C2 |
| METHOD FOR PRODUCTION OF COLLAGEN-LAMININ MATRIX FOR HEALING OF ULCERS, BURNS AND WOUNDS OF HUMAN SKIN | 2018 |
|
RU2736480C2 |
